Last reviewed 2026-04-19 · How we verify

Lower respiratory tract infection

Approved treatments

• Cefradex · Bristol-Myers Squibb
• Cefaprin · Bristol-Myers Squibb
• Amoxycillin · King George's Medical University
• Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
• Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
  Cefazolin is an antibacterial drug that inhibits bacterial cell wall synthesis.
• Vancocin · ANI Pharmaceuticals
• Claforan · Sterimax
• Methocillin S · GSK
• Ceclor
• Ceftin · GSK
  Ceftin works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death.
• Metro I.V. In Plastic Container · Baxter
• Pipracil
  Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death.
• Amoxil · Generic (originally Beecham/GSK)
  Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins.
• Ciprofloxacine · Poitiers University Hospital
• Cefadole
  Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Ceftriaxon · Centre Hospitalier Universitaire Vaudois
• Azactam · Bristol-Myers Squibb
  Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
• Primaxin · Merck Sharp & Dohme B.V.
  Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Fortaz · Pai Holdings Pharm
  Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death.
• Monocid
• Cefotan
• Primaxin · Merck & Co.
  Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body.
• Cephalotin · Eli Lilly
• Zinacef · GSK
  Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Fortaz · Pai Holdings Pharm
  Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance.
• Noroxin
• Floxin
• Epocelin
• Zefazone
• Cipro · Bayer AG
• Rocephin · Generic (originally Roche)
• Bactocill In Plastic Container · Apothecon
• Cephradin · Sohag University
• Cephazolin · HaEmek Medical Center, Israel
• Cefazoline · Nantes University Hospital
• Ceftazidim · Tel-Aviv Sourasky Medical Center
• Metronidazol · University of Oslo
• Ofloxacine · Assistance Publique - Hôpitaux de Paris
• Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• Lower respiratory tract infection patent landscape — cliff calendar, originator estates, attackable patents
• Lower respiratory tract infection treatment landscape brief
• Lower respiratory tract infection treatment updates RSS

Frequently asked questions about Lower respiratory tract infection

Related

• Treatment landscape: Lower respiratory tract infection patent cliff · Lower respiratory tract infection CI report
• Treatment: Cefradex · Bristol-Myers Squibb
• Treatment: Cefaprin · Bristol-Myers Squibb
• Treatment: Amoxycillin · King George's Medical University
• Treatment: Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
• Treatment: Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
• All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing